Edition:
India

AnGes Inc (4563.T)

4563.T on Tokyo Stock Exchange

388JPY
10:09am IST
Change (% chg)

¥-5 (-1.27%)
Prev Close
¥393
Open
¥395
Day's High
¥403
Day's Low
¥384
Volume
946,100
Avg. Vol
1,028,859
52-wk High
¥884
52-wk Low
¥334

Chart for

About

AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of... (more)
No analyst recommendations are available for .

Overall

Beta: 1.59
Market Cap(Mil.): ¥50,402.51
Shares Outstanding(Mil.): 78.63
Dividend: --
Yield (%): --

Financials

BRIEF-AnGes submits application for marketing approval for HGF gene therapy

* Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI)

22 Jan 2018

Earnings vs. Estimates